www.fdanews.com/articles/95431-biomira-files-investigational-new-drug-application-for-px-478
Biomira Files Investigational New Drug Application for PX-478
July 3, 2007
Biomira announced that it has submitted an investigational new drug (IND) application to the U.S. Food and Drug Administration for PX-478. PX-478 has been shown in preclinical studies to inhibit hypoxia-inducible factor (HIF)-1 alpha, a protein that controls the transcription of a number of genes whose products are important for tumor growth and survival.
Biomira